NEXTGEN HEALTHCARE, INC.: 10-Q filed 2010-11-04
What NEXTGEN HEALTHCARE, INC. reported in its quarterly report filed 2010-11-04 (fiscal Q2 2010): 38 published measures, 100 facts as tagged in accession 0000950123-10-100367.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2010-11-04
- Fiscal period
- fiscal Q2 2010
- Accession
- 0000950123-10-100367 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All NEXTGEN HEALTHCARE, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 328,448,000 | USD | |
| At 2010-03-31 | 310,180,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 126,992,000 | USD | |
| At 2010-03-31 | 121,891,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 201,456,000 | USD | |
| At 2010-03-31 | 188,289,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 106,852,000 | USD | |
| At 2010-03-31 | 84,611,000 | USD | |
| At 2009-09-30 | 75,429,000 | USD | |
| At 2009-03-31 | 70,180,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 13,430,000 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 25,522,000 | USD | 183 |
| 2009-07-01 to 2009-09-30 | 11,820,000 | USD | 92 |
| 2009-04-01 to 2009-09-30 | 22,166,000 | USD | 183 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-09-30 | 36,710,000 | USD | 183 |
| 2009-04-01 to 2009-09-30 | 22,883,000 | USD | 183 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-09-30 | -14,197,000 | USD | 183 |
| 2009-04-01 to 2009-09-30 | -11,321,000 | USD | 183 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-09-30 | -272,000 | USD | 183 |
| 2009-04-01 to 2009-09-30 | -6,313,000 | USD | 183 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 73,892,000 | USD | |
| At 2010-03-31 | 65,729,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 28,935,000 | shares | 92 |
| 2010-04-01 to 2010-09-30 | 28,915,000 | shares | 183 |
| 2009-07-01 to 2009-09-30 | 28,597,000 | shares | 92 |
| 2009-04-01 to 2009-09-30 | 28,545,000 | shares | 183 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 29,078,000 | shares | 92 |
| 2010-04-01 to 2010-09-30 | 29,066,000 | shares | 183 |
| 2009-07-01 to 2009-09-30 | 28,742,000 | shares | 92 |
| 2009-04-01 to 2009-09-30 | 28,717,000 | shares | 183 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 0.46 | USD/shares | 92 |
| 2010-04-01 to 2010-09-30 | 0.88 | USD/shares | 183 |
| 2009-07-01 to 2009-09-30 | 0.41 | USD/shares | 92 |
| 2009-04-01 to 2009-09-30 | 0.78 | USD/shares | 183 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 0.46 | USD/shares | 92 |
| 2010-04-01 to 2010-09-30 | 0.88 | USD/shares | 183 |
| 2009-07-01 to 2009-09-30 | 0.41 | USD/shares | 92 |
| 2009-04-01 to 2009-09-30 | 0.77 | USD/shares | 183 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 7,587,000 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 14,576,000 | USD | 183 |
| 2009-07-01 to 2009-09-30 | 6,852,000 | USD | 92 |
| 2009-04-01 to 2009-09-30 | 12,964,000 | USD | 183 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 8,728,000 | USD | |
| At 2010-03-31 | 8,432,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-09-30 | 1,864,000 | USD | 183 |
| 2009-04-01 to 2009-09-30 | 1,319,000 | USD | 183 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 20,823,000 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 39,850,000 | USD | 183 |
| 2009-07-01 to 2009-09-30 | 18,613,000 | USD | 92 |
| 2009-04-01 to 2009-09-30 | 34,935,000 | USD | 183 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 236,688,000 | USD | |
| At 2010-03-31 | 220,221,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 106,409,000 | USD | |
| At 2010-03-31 | 101,286,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 5,972,000 | USD | |
| At 2010-03-31 | 3,342,000 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 46,189,000 | USD | |
| At 2010-03-31 | 46,189,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 112,506,000 | USD | |
| At 2010-03-31 | 107,458,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 30,506,000 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 62,547,000 | USD | 183 |
| 2009-07-01 to 2009-09-30 | 24,774,000 | USD | 92 |
| 2009-04-01 to 2009-09-30 | 49,201,000 | USD | 183 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 1,483,000 | USD | |
| At 2010-03-31 | 1,340,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 51,329,000 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 102,397,000 | USD | 183 |
| 2009-07-01 to 2009-09-30 | 43,387,000 | USD | 92 |
| 2009-04-01 to 2009-09-30 | 84,136,000 | USD | 183 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 24,829,000 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 51,067,000 | USD | 183 |
| 2009-07-01 to 2009-09-30 | 20,061,000 | USD | 92 |
| 2009-04-01 to 2009-09-30 | 40,154,000 | USD | 183 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 5,232,000 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 10,688,000 | USD | 183 |
| 2009-07-01 to 2009-09-30 | 4,346,000 | USD | 92 |
| 2009-04-01 to 2009-09-30 | 8,323,000 | USD | 183 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 28,956,000 | shares | |
| At 2010-03-31 | 28,879,000 | shares |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 18,550,000 | USD | |
| At 2010-03-31 | 20,145,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 4,494,000 | USD | |
| At 2010-03-31 | 3,647,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 7,354,000 | USD | |
| At 2010-03-31 | 7,389,000 | USD |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-09-30 | 1,970,000 | USD | 183 |
| 2009-04-01 to 2009-09-30 | 1,798,000 | USD | 183 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-09-30 | 1,595,000 | USD | 183 |
| 2009-04-01 to 2009-09-30 | 725,000 | USD | 183 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-09-30 | -397,000 | USD | 183 |
| 2009-04-01 to 2009-09-30 | -631,000 | USD | 183 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-09-30 | 11,882,000 | USD | 183 |
| 2009-04-01 to 2009-09-30 | 12,363,000 | USD | 183 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-09-30 | 7,034,000 | USD | 183 |
| 2009-04-01 to 2009-09-30 | 8,816,000 | USD | 183 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-09-30 | 143,000 | USD | 183 |
| 2009-04-01 to 2009-09-30 | 120,000 | USD | 183 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-09-30 | 2,630,000 | USD | 183 |
| 2009-04-01 to 2009-09-30 | 558,000 | USD | 183 |
Inspect the source
- Entity
- NEXTGEN HEALTHCARE, INC. / CIK 0000708818
- Captured
- SEC response SHA-256
8a3d871a9fad696945e3bd127bbbd0879629d56e04d003074ecd6b3f28e88fef
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000708818.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))